tiprankstipranks
ProMIS Neurosciences initiates Phase 1b trial in Alzheimer’s disease
PremiumThe FlyProMIS Neurosciences initiates Phase 1b trial in Alzheimer’s disease
1M ago
ProMIS Neurosciences reports Q3 EPS 31c vs (19c) last year
Premium
The Fly
ProMIS Neurosciences reports Q3 EPS 31c vs (19c) last year
3M ago
ProMIS Neurosciences presents data from PMN310 Phase1a trial
Premium
The Fly
ProMIS Neurosciences presents data from PMN310 Phase1a trial
4M ago
ProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
PremiumThe FlyProMIS Neurosciences annouces data on pathogenic role of misfolded SOD1
7M ago
ProMIS Neurosciences presents preclinical data on ABO at AAIC
Premium
The Fly
ProMIS Neurosciences presents preclinical data on ABO at AAIC
7M ago
ProMIS Neurosciences Advances in Alzheimer’s Treatment Trial
Premium
Company Announcements
ProMIS Neurosciences Advances in Alzheimer’s Treatment Trial
7M ago
ProMIS  publishes data on pathogenic proteins as treatment target for ALS
PremiumThe FlyProMIS publishes data on pathogenic proteins as treatment target for ALS
11M ago
ProMIS Neurosciences strengthens global IP portfolio
Premium
The Fly
ProMIS Neurosciences strengthens global IP portfolio
12M ago
ProMIS Neurosciences selects lead vaccine candidate PMN400
Premium
The Fly
ProMIS Neurosciences selects lead vaccine candidate PMN400
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100